SMAD2 and colorectal carcinoma: FLNA ser2152 phosphorylated by c‐Met‐AKT enhanced c‐Met promoter activity by its interaction with smad2 to induce epithelial‐mesenchymal transition, promoting chemoresistance of CRC.22